Recent standardization of treatment strategy for pancreatic neuroendocrine tumors

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

426

HTML

5126

Figures (1-3)

407

Tables (1-1)

216

Sum=6175

Sep 28, 2010 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Sep 28, 2010; 16(36): 4519-4525
Published online Sep 28, 2010. doi: 10.3748/wjg.v16.i36.4519

Table 1 World Health Organization classification of pancreatic neuroendocrine tumors

WHO classification	Well-differentiated neuroendocrine tumor	Well-differentiated neuroendocrine carcinoma	Poorly-differentiated neuroendocrine carcinoma
Biological behavior	Benign/uncertain behavior	Low malignancy	High malignancy
Metastases	-	+	+
Ki-67/MIB-1 index (%)	< 2	2-20	> 20
Pathological differentiation	Well-differentiated	Well-differentiated	Poorly-differentiated
Vascular invasion	-/+	+	+
Size (diameter)	≤ 2 cm	> 2 cm	Any size

Alteration of the original Table by Klöppel[4]. WHO: World Health Organization.

Citation: Imamura M. Recent standardization of treatment strategy for pancreatic neuroendocrine tumors. World J Gastroenterol 2010; 16(36): 4519-4525
URL: https://www.wjgnet.com/1007-9327/full/v16/i36/4519.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i36.4519